In our study, we observed newly acquired mutations at AML transformation, including in genes involved in signaling pathways (NRAS, FLT3, JAK2, PTPN11, and CBL), as well as in RUNX1 and ASXL1. The gene discussed is PTPN11; the disease is acute myeloid leukemia.